Aspiration of Subglottic Secretions Using Hi-Lo Evac Endotracheal Tube: Tube Size and Incidence of Suction Lumen Dysfunction - Full Text View

Aspiration of Subglottic Secretions Using Hi-Lo Evac Endotracheal Tube: Tube Size and Incidence of Suction Lumen Dysfunction

This study is currently recruiting participants.
Verified by University Hospital, Alexandroupolis, March 2007

Sponsored by:	University Hospital, Alexandroupolis
Information provided by:	University Hospital, Alexandroupolis
ClinicalTrials.gov Identifier:	NCT00450476

Purpose

To evaluate the correlation between endotracheal tube size and incidence of dysfunction of suction lumen of Hi-Lo Evac endotracheal tube in critically ill patients who required mechanical ventilation for more than 48 hours.

Condition	Intervention	Phase
Aspiration of Subglottic Secretions	Device: Hi-Lo Evac Endotracheal Tube	Phase IV

U.S. FDA Resources

Study Type:	Observational
Study Design:	Screening, Cross-Sectional, Random Sample, Prospective Study

Official Title:	Aspiration of Subglottic Secretions in Intubated Critically Ill Patients Using Hi-Lo Evac Endotracheal Tube: Correlation Between Tube Size and Incidence of Suction Lumen Dysfunction

Further study details as provided by University Hospital, Alexandroupolis:

Estimated Enrollment:	60
Study Start Date:	January 2007

Detailed Description:

In mechanically ventilated patients, aspiration of subglottic secretions is a widely used intervention for prevention of ventilator-associated pneumonia. Using Hi–Lo® Evac endotracheal tube (Hi-Lo Evac; Mallinckrodt; Athlone, Ireland), dysfunction of suction lumen and subsequent failure to aspirate the subglottic secretions is not uncommon. The objective of this prospective observational study is to determine the causes and the incidence of suction lumen dysfunction of Evac endotracheal tube.

Eligibility

Ages Eligible for Study:	18 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Critically ill patients with orotracheal intubation and anticipated duration of intubation more than 48 hours

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00450476

Contacts


Contact: Christos K Dragoumanis, MD, PhD	00302551075085	christosdragoumanis@gmail.com

Locations


Greece, Evros
	University General Hospital of Alexandroupolis	Recruiting
	Alexandroupolis, Evros, Greece, 68100
	Principal Investigator: Christos K Dragoumanis, MD, PhD
	Sub-Investigator: Vassilios Papaiannou, MD, PhD
	Sub-Investigator: Dimitrios Konstantonis, MD, PhD

Sponsors and Collaborators

University Hospital, Alexandroupolis

Investigators


Principal Investigator:	Christos K Dragoumanis, MD, PhD	Intensive Care Unit, University Hospital of Alexandroupolis

More Information

Study ID Numbers:	30/3/25-01-2007
First Received:	March 21, 2007
Last Updated:	March 21, 2007
ClinicalTrials.gov Identifier:	NCT00450476
Health Authority:	Greece: Ethics Committee

Keywords provided by University Hospital, Alexandroupolis:

ventilator associated pneumonia

prevention

endotracheal intubation

mechanical ventilation

Study placed in the following topic categories:

Critical Illness

Pneumonia, Ventilator-Associated

Pneumonia

ClinicalTrials.gov processed this record on September 19, 2008